BioSpace News Archive

The World Federation of Neurology is joining forces with the World Health Organization to create global standards of neurological care.

CELLINK publishes the quarterly report for the period 1st of June 2019 – 31st of August 2019 and for the full year of operations 2018-2019.

Imugene Limited announced that prominent City of Hope researchers Yanghee Woo, MD, Associate Clinical Professor, Department of Surgery and Director, Gastroenterology Minimally Invasive Therapy Program, together with Yuman Fong, MD, Professor and Chair of the Department of Surgery, received a AU$564,173 US Department of Defense Grant

Partly because the bidding for these contracts remain confidential, critics are questioning the secrecy and whether these deals actually are financially beneficial.

The new data could boost the company’s chances of securing regulatory approval.

Although the clinical trial news last week was dominated by the stunning reversal of Biogen and Eisai’s clinical trials of aducanumab for Alzheimer’s disease, there was plenty of other trial news. Here’s a look.

Innovative approach for hard-to-treat cancers being developed at the Cancer Research UK Beatson Institute

In its announcement on Thursday, the FDA said its preliminary tests of alternative antacid treatments such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) currently show no NDMA at this time based on testing.

On Thursday, FTC staff reviewing Roche’s $4.8 billion bid for Spark gave the deal a thumbs up after reviewing the potential merger.

Innovia Medical announced its partnership with DTR Medical.